Jade Biosciences, Inc. JBIO
15.04 USD +0.47 (+3.23%)
At closeNov 4, 2026, 4:01 PM EST
15.04 0.00 0.00%
After hours · Nov 4, 4:01 PM ET
14.45 Day range 15.19
8.36 52-week range 28.00
- YTD
- -2.53%
- 1 year
- +67.11%
Financial health
Altman Z-Score
17.05 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 2
Valuation
P/E -3.8×
FY 2020 5y median -7.9× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 1.5×
FY 2020 5y median 1.7× FY 2025
P/FCF -5.1×
FY 2020 5y median -10.4× FY 2025
EV/EBITDA -3.1×
FY 2020 5y median -7.6× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -19.6%
FY 2020 5y median -9.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -38.3%
FY 2020 5y median -40.6% FY 2025
ROIC -34.1%
FY 2020 5y median -41.6% FY 2025
ROA -36.4%
FY 2020 5y median -38.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income -52.2%
FY 2020 FY 2025
EPS (diluted) 95.2%
FY 2020 FY 2025
Free Cash Flow -33.3%
FY 2020 FY 2025
Financial Health
Current Ratio 20.3×
FY 2020 5y median 20.3× FY 2025
Quick Ratio 20.3×
FY 2020 5y median 20.3× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2020 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 15.6%
FY 2020 5y median 0.0% FY 2025
Payout Ratio -59.1%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31